Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 23, 2015

View Archived Issues

HIV Vaccine Trials Network launches phase I/II trial of prime-boost vaccine

IDRI receives BARDA funding to establish adjuvant hub

E Keppra approved in Japan as monotherapy for partial-onset seizures

Queen Mary University of London and Takeda to develop new gastroenterology therapies

Cerecor acquires kappa opioid receptor antagonist from Eli Lilly

Anti-IL-23 antibody shows clinical effect in Crohn's disease patients

Vichem Chemie Research discloses new FLT3 inhibitors

Anti-MZGP2 antibodies associated with Crohn's disease phenotypes

Actelion Pharmaceuticals patents new lipoxin receptor agonists

Roche patent reports new fusion proteins for Alzheimer's type dementia

New SHIP-2 inhibitors for diabetes designed by University of Toyama

Merck KGaA discloses multiple kinase inhibitors

Novo Nordisk reports positive results from phase II trial of oral semaglutide in type 2 diabetes

Valeant to acquire Salix Pharmaceuticals

Investigators prepare new anti-GARP MAbs

Allergan patents S1P1 receptor ligands

Sosei acquires Heptares Therapeutics

FDA grants orphan drug status to polidocanol for venous malformations

FDA grants priority review to Rapamune sNDA for lymphangioleiomyomatosis

AB-Biotics collaborates with Derbycare to launch AB-Kolicare in China

Shire completes acquisition of NPS Pharmaceuticals

First stem cell-based medicinal product approved in Europe

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...